1. SARS-CoV-2 infection in multiple sclerosis: results of the Spanish Neurology Society Registry;Arrambide;Neurol.-Neuroimmunol. Neuroinflamm.,2021
2. Association of disease-modifying therapies with COVID-19 susceptibility and severity in patients with multiple sclerosis: a systematic review and network meta-analysis;Barzegar;Mult. Scler. Int.,2022
3. Association of disease-modifying therapies with COVID-19 susceptibility and severity in patients with multiple sclerosis: a systematic review and network meta-analysis;Barzegar;Mult. Scler. Int.,2022
4. COVID-19 among patients with multiple sclerosis: a systematic review;Barzegar;Neurol.-Neuroimmunol. Neuroinflamm.,2021
5. Characteristics of COVID-19 disease in multiple sclerosis patients;Barzegar;Mult. Scler. Rel. Disord.,2020